These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15808469)
1. Inhibitory activities against topoisomerase I and II by isoaurostatin derivatives and their structure-activity relationships. Suzuki K; Okawara T; Higashijima T; Yokomizo K; Mizushima T; Otsuka M Bioorg Med Chem Lett; 2005 Apr; 15(8):2065-8. PubMed ID: 15808469 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship. Abdel-Aziz M; Matsuda K; Otsuka M; Uyeda M; Okawara T; Suzuki K Bioorg Med Chem Lett; 2004 Apr; 14(7):1669-72. PubMed ID: 15026047 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives. Riou JF; Helissey P; Grondard L; Giorgi-Renault S Mol Pharmacol; 1991 Nov; 40(5):699-706. PubMed ID: 1658605 [TBL] [Abstract][Full Text] [Related]
4. Preparation of yuanhuacine and relative daphne diterpene esters from Daphne genkwa and structure-activity relationship of potent inhibitory activity against DNA topoisomerase I. Zhang S; Li X; Zhang F; Yang P; Gao X; Song Q Bioorg Med Chem; 2006 Jun; 14(11):3888-95. PubMed ID: 16488610 [TBL] [Abstract][Full Text] [Related]
5. Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA). Bridewell DJ; Finlay GJ; Baguley BC Anticancer Drug Des; 2001 Dec; 16(6):317-24. PubMed ID: 12375884 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of DNA topoisomerases I and II and cytotoxicity by lignans from Saururus chinensis. Lee YK; Seo CS; Lee CS; Lee KS; Kang SJ; Jahng Y; Chang HW; Son JK Arch Pharm Res; 2009 Oct; 32(10):1409-15. PubMed ID: 19898804 [TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors. Han S; Xiao Z; Bastow KF; Lee KH Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972 [TBL] [Abstract][Full Text] [Related]
8. Effect of yerba mate (Ilex paraguariensis) tea on topoisomerase inhibition and oral carcinoma cell proliferation. Gonzalez de Mejia E; Song YS; Ramirez-Mares MV; Kobayashi H J Agric Food Chem; 2005 Mar; 53(6):1966-73. PubMed ID: 15769122 [TBL] [Abstract][Full Text] [Related]
9. Understanding topoisomerase I and II in terms of QSAR. Verma RP Bioorg Med Chem; 2005 Feb; 13(4):1059-67. PubMed ID: 15670914 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, cytotoxic activity, DNA topoisomerase-II inhibition, molecular modeling and structure-activity relationship of 9-anilinothiazolo[5,4-b]quinoline derivatives. Loza-Mejía MA; Olvera-Vázquez S; Maldonado-Hernández K; Guadarrama-Salgado T; González-Sánchez I; Rodríguez-Hernández F; Solano JD; Rodríguez-Sotres R; Lira-Rocha A Bioorg Med Chem; 2009 May; 17(9):3266-77. PubMed ID: 19364657 [TBL] [Abstract][Full Text] [Related]
11. BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo. Demarquay D; Huchet M; Coulomb H; Lesueur-Ginot L; Lavergne O; Camara J; Kasprzyk PG; Prévost G; Bigg DC Cancer Res; 2004 Jul; 64(14):4942-9. PubMed ID: 15256467 [TBL] [Abstract][Full Text] [Related]
12. DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties. Har-Vardi I; Mali R; Breietman M; Sonin Y; Albotiano S; Levitas E; Potashnik G; Priel E Hum Reprod; 2007 Aug; 22(8):2183-9. PubMed ID: 17656417 [TBL] [Abstract][Full Text] [Related]
13. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors. Shuai L; Wang S; Zhang L; Fu B; Zhou X Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725 [TBL] [Abstract][Full Text] [Related]
14. [Inhibitors of DNA topoisomerases]. Andoh T Gan To Kagaku Ryoho; 1997 Sep; 24(11):1526-35. PubMed ID: 9309151 [TBL] [Abstract][Full Text] [Related]
15. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome. Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647 [TBL] [Abstract][Full Text] [Related]
16. Phenoxodiol (2H-1-benzopyran-7-0,1,3-(4-hydroxyphenyl)), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex. Constantinou AI; Husband A Anticancer Res; 2002; 22(5):2581-5. PubMed ID: 12529967 [TBL] [Abstract][Full Text] [Related]
17. Inhibitors of DNA topoisomerase I and II isolated from the Coptis rhizomes. Kobayashi Y; Yamashita Y; Fujii N; Takaboshi K; Kawakami T; Kawamura M; Mizukami T; Nakano H Planta Med; 1995 Oct; 61(5):414-8. PubMed ID: 7480201 [TBL] [Abstract][Full Text] [Related]
18. Topoisomerase I and II inhibitory constituents from the bark of Tilia amurensis. Choi JY; Seo CS; Zheng MS; Lee CS; Son JK Arch Pharm Res; 2008 Nov; 31(11):1413-8. PubMed ID: 19023537 [TBL] [Abstract][Full Text] [Related]
19. Synthetic lanostane-type triterpenoids as inhibitors of DNA topoisomerase II. Wada S; Tanaka R Bioorg Med Chem Lett; 2005 Jun; 15(12):2966-9. PubMed ID: 15914002 [TBL] [Abstract][Full Text] [Related]
20. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs. Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]